EXPLEOSOL NSI Week ended 07 Aug 2026

Weekly Investor Report

Expleo Solutions Limited · Technology · Information Technology Services

Latest close 836.8 INR
3.7% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 4.3% above the Trend Line and sits at 36.8% of its 52-week range. The latest completed week returned 3.7%, after a 17.4% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal.

Setup score 26 out of 100
Latest Close 836.8 INR 7 Aug 2026
1W Return 3.7% latest completed week
4W Return 17.4% short-term follow-through
12W Return -5.5% quarterly tape
Trend Breadth 11.5% 6 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 41.97% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 4.3% above the Trend Line and sits at 36.8% of its 52-week range. The latest completed week returned 3.7%, after a 17.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0812-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.08Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 17.4% over four weeks, -5.5% over 12 weeks, and -24.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W3.7%
4W17.4%
12W-5.5%
26W-4.3%
52W-24.9%
Active trend streak0 weeks
Active weeks in one year6
Trend breadth11.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.19Latest activity-pressure read.
Pressure change-1591.4%Four-week change in activity pressure.
Leadership-5.69Latest relative-leadership reading.
RS change73.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength91/100Blend of value, momentum, and quality. Underlying universe rank 10; rank 1 is best.
Value97/100Relative valuation strength. Underlying universe rank 4; rank 1 is best.
Quality89/100Profitability and accounting quality. Underlying universe rank 12; rank 1 is best.
Momentum11/100Medium-term price momentum. Underlying universe rank 90; rank 1 is best.
Growth41/100Revenue and earnings growth. Underlying universe rank 60; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework100/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
10.5x
Price divided by trailing earnings.
Price / sales
1.2x
Market value relative to trailing revenue.
EV / EBITDA
4.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
12.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
36.4%
Gross profit retained from each unit of revenue.
Operating margin
17.6%
Operating profit retained from revenue.
Free-cash-flow margin
10.5%
Free cash flow generated from revenue.
Return on invested capital
34.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
8.1%
Latest one-year revenue growth.
EPS growth
20.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-32.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
13.1%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
13.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 24 relevant articles.

4 positive · 20 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-28.8%Distance below the 52-week high.
13-week volatility6.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+14.6%Week of 31 Jul.
Worst week-10.4%Week of 26 Jun.
Latest week+3.7%Week of 7 Aug.

Shape of recent returns

Strong gains5
Modest gains7
Flat weeks0
Modest losses10
Sharp losses4
Recent vol6.0%13-week weekly-return volatility.
Base vol4.6%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew3.8% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026836.8 INR3.7%802.1 INR1,101 INR-0.19-5.69177.5KOff
31 Jul 2026807.0 INR14.6%806.1 INR1,104 INR-0.28-8.912.0MOff
24 Jul 2026704.3 INR1.2%811.6 INR1,110 INR-0.41-19.06105.3KOff
17 Jul 2026696.3 INR-2.3%821.2 INR1,115 INR-0.24-22.6468.7KOff
10 Jul 2026712.5 INR-0.9%832.3 INR1,120 INR0.01-21.23413.4KOff
3 Jul 2026718.8 INR-1.0%842.6 INR1,126 INR0.15-21.5717.7KOff
26 Jun 2026726.1 INR-10.4%853.7 INR1,131 INR0.34-20.930Off
19 Jun 2026810.5 INR3.3%866.6 INR1,136 INR0.53-12.4719.7KOff
12 Jun 2026784.8 INR-8.4%875.5 INR1,140 INR0.65-14.5125.9KOff
5 Jun 2026857.1 INR-2.0%885.1 INR1,145 INR0.89-6.4138.8KOff
29 May 2026874.2 INR-3.1%889.2 INR1,149 INR0.83-5.47105.6KOff
22 May 2026901.8 INR1.8%893.9 INR1,153 INR0.70-3.46321.8KOff
15 May 2026885.7 INR5.1%897.8 INR1,156 INR0.50-5.032.8MOff
8 May 2026842.5 INR3.5%901.9 INR1,160 INR0.24-11.6565.9KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context